Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 capsid protein p24 is a major structural component of the human immunodeficiency virus type 1 (HIV-1) and plays a central role in the viral life cycle. It forms the conical core that encapsulates the viral RNA-nucleocapsid complex within each virion. It is considered an attractive target for antiretroviral therapy. Small molecule inhibitors and peptides targeting p24 have shown to inhibit virus replication.
Capsid assembly disruption, capsid stabilization
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 Capsid Protein p24 (p24).